Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262039 · ClinicalTrials.gov registry record · NA
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02262039 is a NA study that has completed, run by Yale University. The registered enrollment target is 41 participants.
The verdict
NCT02262039, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
Interventions
- DEVICE Valveless recirculating insufflation (VTI)
- DEVICE Conventional pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02262039
The ClinicalTrials.gov registry entry for NCT02262039 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Valveless recirculating insufflation (VTI) is the first listed.
NCT02262039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02262039 about?
NCT02262039 is a clinical study titled "Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System". The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
What is the current status of trial NCT02262039?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-08. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02262039?
The interventions under investigation include: Valveless recirculating insufflation (VTI) (DEVICE), Conventional pressure (DEVICE).
Who is sponsoring clinical trial NCT02262039?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.